-
Below is a three month price history chart comparing the stock performance of MYGN vs.
FORBES: Myriad Genetics Larger Than S&P 500 Component Apollo Group
-
At the closing bell, MYGN is down about 0.1%, while APOL is trading flat on the day Friday.
FORBES: Myriad Genetics Larger Than S&P 500 Component Apollo Group
-
In June, Myriad Genetics (nasdaq: MYGN - news - people ) said its Flurizan anti-amyloid drug was totally ineffective in a final-stage trial.
FORBES: Alzheimer's Drug Showdown
-
V. ( NASD: QGEN) is off about 2.6%, Illumina Inc ( NASD: ILMN) is down about 0.3%, and Myriad Genetics, Inc. ( NASD: MYGN) is lower by about 1.1%.
FORBES: FBT, QGEN, ILMN, MYGN: ETF Outflow Alert
-
Myriad Genetics (MYGN), a leading developer of molecular diagnostic and therapeutic products, is predictably on track to expand its pipeline and broaden its markets in the U.S. and overseas.
FORBES: Myriad Genetics: This Leading Developer of Diagnostic Products Is Catching The Eye Of Potential Big Pharma Partners
-
Salt Lake City-based Myriad Genetics mygn (nasdaq: mygn - news - people) has been finding genes in a Mormon population in its hometown since its inception in 1991.
FORBES: Choppy IPO For deCode Genetics
-
In research published in tomorrow's issue of Cell, scientists at Salt Lake City-based Myriad Genetics (nasdaq: MYGN - news - people ) and the University of Utah identify exactly which protein the virus appropriates in this microscopic hijacking.
FORBES: Myriad Genetics On HIV Drug Trail
-
Among the largest underlying components of FBT, in trading today Biogen Idec Incorporated ( NASD: BIIB) is up about 6.8%, Myriad Genetics Incorporated ( NASD: MYGN) is up about 3.9%, and Vertex Pharmaceuticals Incorporated ( NASD: VRTX) is higher by about 1.8%.
FORBES: Noteworthy ETF Inflows: FBT, BIIB, MYGN, VRTX
-
Only months later, Hitachi (nyse: HIT - news - people) and Oracle (nasdaq: ORCL - news - people) successfully announced a similar partnership with Myriad Genetics (nasdaq: MYGN - news - people), a biotechnology company.
FORBES: Magazine Article